openPR Logo
Press release

Surge in DNA Sequencing Boosts Epigenetics Market to $4.7 Billion by 2031

10-18-2024 10:14 PM CET | Associations & Organizations

Press release from: ABNewswire

Epigenetics Market

Epigenetics Market

Epigenetics Market size was valued at USD 1.6 billion in 2023 to USD 4.7 billion by 2031, growing at a CAGR of 14.8% in the forecast period (2024-2031).
Epigenetics Market [https://www.skyquestt.com/report/epigenetics-market] size was valued at USD 1.6 billion in 2023 to USD 4.7 billion by 2031, growing at a CAGR of 14.8% in the forecast period (2024-2031). The demand for epigenetics market is increasing exponentially due to the vital part epigenetics play in analysing gene regulation apart from DNA sequencing. It also helps in researching about various diseases and advancing personalized medicines. The market leaders and startups operating in this sector are cumulatively investing for advancing the epigenetic domain. Epigenetics refers to the investigation of transformations in heritable phenotype that happens without any changes to the DNA sequencing.

The growing application of epigenetics is also boosting the growth of the market. Moreover, increasing cardiovascular diseases, cancer, and genetic disorders along with improved research and development activities in DND sequencing are supporting the market growth. Furthermore, the growing aging population in various nations is positively influencing the development of the epigenetics market. Epigenetics drugs are utilized to prevent various enzymes like HDMs, HMTs, DNMTs, HATs, and HDACs, in epigenetic disorders. They can efficiently function with other therapies, like immunotherapy or chemotherapy. The growing incidences of cancer along with the rising emphasis of market leaders to treat cancer and other diseases, the market will continuously witness significant growth.

Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/epigenetics-market

Increasing Research and Development to Improve Drug Discovery

Recently, the epigenetic modifications are gaining recognition as it is prooving to be extremely useful targets for drug discovery, which is propelling the market growth. Pharmaceutical companies have started heavily investing in epigenetic research for developing advanced therapies. In cancer treatment, drugs like Azacitidine and Decitabine, which target DNA methylation, have bought immense evolution in the therapy options, highlighting the capability of the market. Furthermore, constant research into epigenetic therapies that can be used for neurological disorders and autoimmune diseases is also further progressing and advancing the market.

Growing Personalized Medicine and Drug Development to Develop Precise Treatment for Cancer

The profiling of epigenetic helps personalized medicine to customize treatments according to the patient's unique epigenetic profile. This method is extremely vital in advancing targeted therapies and drug discovery. This is boosting the adoption of epigenetic technologies by pharmaceutical and biotechnology firms. In oncology, epigenetic markers are helping in the development of accurate cancer treatments, enhancing the efficiency and patient outcomes. This growing emphasis on personalized therapies is immensely contributing to the growth of epigenetics market.

In December 2023, BioLabs extended their joint venture with Promega. This joint initiavtive will help in increasing the speed of life sciences innovation worldwide by supporting early-stage startups.

In November 2023, QIAGEN strategically collaborated with Element Biosciences, Inc. This will help them in offering a wide range of NGS workflows for the advanced Element AVITI System.

In October 2023, Zenith Epigenetics Ltd. engaged into an agreement with Cencora for commercializing the ZEN-3694 program. It is an advanced process for improving the efficieny of treating cancer of presently marketed drugs.

For a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/epigenetics-market

This Market Consist of the Following Segments

Product Type

Reagents

Kits

Instruments

Enzymes

Technology

DNA Methylation

Histone Methylation

Histone Acetylation

MicroRNA Modification

Other Epigenetic Modifications

Application

Oncology

Cardiovascular Diseases

Metabolic Diseases

Neurological Disorders

Immunology

Top Player's Company Profiles

AbbVie Inc.

AstraZeneca PLC

Bayer AG

BeiGene Ltd.

Bristol Myers Squibb Company

Epizyme, Inc.

GlaxoSmithKline PLC

Incyte Corporation

Johnson & Johnson

Merck & Co., Inc.

Novartis AG

Pfizer Inc.

Regeneron Pharmaceuticals, Inc.

Roche Holding AG

Seattle Genetics, Inc.

Takeda Pharmaceutical Company Limited

Targovax, Inc.

Vertex Pharmaceuticals Incorporated

Vivid Biosciences Inc.

Zymeworks Inc.

Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/epigenetics-market

Incorporation of Epigenetics with Omics Technologies to Better Understand Biological Systems

The incorporation of epigenetics with other omics technologies, like genomics and proteomics, improves the understanding of biological systems. This is increasing the demand for multi-omics platforms, boosting the market growth. Furthermore, by combining epigenetic data with genomic and transcriptomic data helps the researchers to analyze the complex gene regulatory networks. This helps in better understanding the diseases and drug development, further progressing the market forward.

To read the full report, please visit: https://www.skyquestt.com/report/epigenetics-market

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=surge-in-dna-sequencing-boosts-epigenetics-market-to-47-billion-by-2031]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/epigenetics-market



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Surge in DNA Sequencing Boosts Epigenetics Market to $4.7 Billion by 2031 here

News-ID: 3700838 • Views:

More Releases from ABNewswire

VIP Auto PA: Auto Brokers Near Me Redefine Transparent Car Leasing in Feasterville-Trevose
VIP Auto PA: Auto Brokers Near Me Redefine Transparent Car Leasing in Feastervil …
VIP Auto PA continues serving Pennsylvania with transparent, factory-direct car leasing services from its Feasterville-Trevose location, offering zero-down options and no-haggle pricing across all vehicle makes and models. Feasterville-Trevose, PA - The traditional car-buying experience has long frustrated consumers with high-pressure sales tactics and inflated pricing structures. VIP Auto PA [http://www.vipautopa.com/] continues addressing these industry pain points through a customer-centric brokerage model that has served Pennsylvania drivers since 2007. Operating from
Austin Nail Salon Dream Spa Expands Service Menu with Apres Gel-X and Holistic Wellness Treatments
Austin Nail Salon Dream Spa Expands Service Menu with Apres Gel-X and Holistic W …
Dream Spa in Austin expands with Apres Gel-X nails, infrared sauna, and head spa treatments, offering comprehensive beauty and wellness services at its Airport Boulevard location near downtown Austin. Dream Spa [https://www.dreamspaatx.com/], located at 5301 Airport Blvd, Suite 200 in Austin, Texas, has announced the expansion of its service offerings to include authentic Apres Gel-X nail extensions, infrared sauna therapy, and signature head spa treatments. The locally established business continues to
Terrance Private Investigator Expands Houston Private Investigator Services with Community Support Program
Terrance Private Investigator Expands Houston Private Investigator Services with …
Terrance Private Investigator launches a Houston community program offering consultation, family case support, and professional investigation services to residents facing sensitive personal matters. A Houston-based investigative firm is taking action to support families facing difficult personal situations. Terrance Private Investigator & Associates [https://piterrance.com/] has announced a new community initiative designed to provide accessible resources and confidential case consultations for residents throughout the Houston area. The program addresses growing concerns among families facing
El Monte Agency Strengthens Home Insurance Options and Community Protection Services
El Monte Agency Strengthens Home Insurance Options and Community Protection Serv …
Marvin Martinez: Allstate Insurance strengthens El Monte's insurance options with bilingual services, comprehensive coverage, and community-focused customer education, earning Elite Agent recognition through consistent service excellence. El Monte, California - The local insurance landscape continues to evolve as Marvin Martinez, of Allstate Insurance [https://agents.allstate.com/marvin-martinez-el-monte-ca.html?utm_source=GMB&utm_medium=Website], reinforces the company's commitment to protecting families and businesses throughout the San Gabriel Valley. The agency's focus on personalized coverage solutions has positioned it as a trusted

All 5 Releases


More Releases for Epigenetic

Nucleic Acid Therapeutics Market Trends Emphasizing Epigenetic and microRNA Modu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nucleic Acid Therapeutics Market - (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Epigenetics Market - Harnessing the Epigenetic Revolution: Transforming the Futu …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Epigenetics Market. Epigenetics Market: https://www.growthplusreports.com/report/epigenetics-market/9171 The Epigenetics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy. The Epigenetics market
Epigenetic Market 2021 | Detailed Report
The Epigenetic research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the Epigenetic industry to
Epigenetic Market Forecast By End-use Industry 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,
Epigenetic Market to Observe Strong Development by 2016-2026
The epigenetic process includes phosphorylation, methylation, sumolyation, acetylation and ubiquitylation etc. of DNA as well as histones resulting in changes in Phenotypes. These changes are modified with environmental conditions. Epigenetic market is now an emerging field. There are various diagnostic tests available now that detect epigenetic changes. There are some FDA approved epigenetic drugs. Other than many diagnostic companies, many biopharmaceutical and pharmaceutical companies are also very active in the
Epigenetic Market Plying for Significant Growth During 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,